Zhongnan Medical Journal Press

Home Results

A total of 5 result was found. Results that relate to Metabolic dysfunction-associated steatotic liver disease

Advances in non-invasive diagnosis of metabolic dysfunction-associated fatty liver disease

Published on New Medicine 2024,34(7):807-816.
14658 times 2797 times

WANG Ziqian WANG Shixu LIU Yihang WANG Chaoyang

Metabolic dysfunction-associated steatotic liver disease Metabolic dysfunction-associated steatohepatitis Hepatic steatosis Liver fibrosis Serum biomarker Diagnosis
Details
Evaluation of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease using ultrasound controlled attenuation parameter combined with clinical features

Published on New Medicine 2024,34(10):1121-1129.
11826 times 2543 times

LIU Chunyu TANG Jingkuan ZHAO Wei

Metabolic dysfunction-associated steatotic liver disease Liver fibrosis Ultrasound Controlled attenuation parameter Machine learning Diagnose
Details
Construction and validation of the diagnostic model for metabolic dysfunction-associated steatotic liver disease among the non-obese population

Published on New Medicine 2025,35(2):141-150.
14144 times 2321 times

WANG Yufeng HU Minxuan LI Yuntao ZHU Kexin JI Guozhong YUAN Yuan

Metabolic dysfunction-associated steatotic liver disease Non-obese Diagnostic model Logistic regression Predictive model
Details
Disease burden of metabolic dysfunction-associated steatotic liver disease in the elderly population globally and in China from 1990 to 2021

Published on New Medicine 2026,36(4):428-437.
1821 times 561 times

ZHANG Qiang ZHAO Xiaoxiao WANG Haibo XU Peng WANG Yaxing ZHAO Xinke LIU Fan LI Jiali HE Tao CHEN Zhengtao Ding Yunhan KE Lixin LI Jieyun XUN Yangqin LU Cuncun

Metabolic dysfunction-associated steatotic liver disease Non-alcoholic fatty liver disease Older adult Disease burden Prediction model
Details
Research progress on food-medicine homology substances in metabolic dysfunc-tion-associated steatotic liver disease

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):839-847.
977 times 171 times

SUN Mingyu LI Ming ZHANG Hao

Food-medicine homology substances Metabolic dysfunction-associated steatotic liver disease Lipid metabolism Liver fibrosis Mechanism of action
Details